Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K T Finn
A Second Course of High-Dose Melphalan and Auto-SCT for the Treatment of Relapsed AL Amyloidosis
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
An Overview of the Use of High-Dose Melphalan With Autologous Stem Cell Transplantation for the Treatment of AL Amyloidosis
Bone Marrow Transplantation
Transplantation
Hematology
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Matched-Pair Analysis to Compare the Outcomes of a Second Salvage Auto-SCT to Systemic Chemotherapy Alone in Patients With Multiple Myeloma Who Relapsed After Front-Line Auto-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Trends in Day 100 and 2-Year Survival After Auto-SCT for AL Amyloidosis: Outcomes Before and After 2006
Bone Marrow Transplantation
Transplantation
Hematology
Auto-SCT for AML in Second Remission: CALGB Study 9620
Bone Marrow Transplantation
Transplantation
Hematology
Primary Central Nervous System Lymphoma: Implication of High-Dose Chemotherapy Followed by Auto-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Current Treatment of AL Amyloidosis
Haematologica
Hematology
Melphalan, Lenalidomide and Dexamethasone for the Treatment of Immunoglobulin Light Chain Amyloidosis: Results of a Phase II Trial
Haematologica
Hematology
Prognostic Value of Comorbidity for Auto-SCT Eligibility and Outcome in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
